Comparative Study of Two Marketed 1-day Soft Contact Lenses
NCT ID: NCT01464255
Last Updated: 2014-08-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2011-08-31
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere
NCT06817785
Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses
NCT03417557
Clinical Performance of Hydrogel vs. Silicone Hydrogel Contact Lenses
NCT02131402
Clinical Performance of Habitual Wearers of Bioclear 1-day Lenses When Refitted With Biomedics 1-day Extra for 1 Week
NCT02406495
Evaluation of the Performance of Different Daily Disposable Lens Designs in Habitual Soft Contact Lens Wearers
NCT04668989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ocufilcon D
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
ocufilcon B
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
ocufilcon B
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
ocufilcon D
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ocufilcon D
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
ocufilcon B
Participants wear a first pair of lenses for one week and then crossover and wear an alternate second pair of lenses for one week.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is able to wear the study lenses for at least eight hours a day, seven days a week
* Aged 18-40 years and has full legal capacity as a volunteer
* Has a distance contact lens prescription from -0.25 and -6.00D inclusive
* Has spectacle astigmatism of \< 1.00D in each eye
* Baseline vision of 20/20 best-corrected in each eye.
* Is correctable to at least 20/25 distance visual acuity with study contact lenses in each eye
* Has read and understood the consent form and willing to sign consent form
* Willing and able to follow participant instructions and attend the required study visits Has worn soft contact lenses for at least two weeks prior to the study (daily wear only).
Exclusion Criteria
* Not a current or past wearer of the ocufilcon B 52% 1-day lenses.
* Has undergone anterior ocular surgery
* Is aphakic
* Has never worn contact lenses before
* Has any systemic disease which clinically contraindicates contact lenses
* Has active ocular disease or severe insufficiency of lacrimal secretion (dry eye)
* Use of systemic or topical medications that will affect ocular health or visual performance
* Slit lamp findings with a grading of greater than 1.0 using the grading scales in Appendix 3
* Not possible to achieve a satisfactory fit with the lens design used in the study
* Has keratoconus or other corneal irregularity
* Participating in another eye-related clinical trial
* Pregnant, lactating or planning a pregnancy
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thao N Yeh, OD
Role: PRINCIPAL_INVESTIGATOR
U.C. Berkeley, School of Optometry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Center, U.C. Berkeley, School of Optometry
Berkeley, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CV-OMC-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.